Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03153475 · ClinicalTrials.gov registry record · NA
ATTUNE Revision System in the Revision Total Knee Arthroplasty Population
A NA study of Revision Total Knee Arthroplasty, sponsored by DePuy Orthopaedics.
- Active
- Registry status
- NA
- Development phase
- 400
- Enrollment target
- 20
- Study locations
NCT03153475: Active NA study of Revision Total Knee Arthroplasty, sponsored by DePuy Orthopaedics.
NCT03153475 is a NA study of Revision Total Knee Arthroplasty that is active but no longer recruiting, run by DePuy Orthopaedics. The registered enrollment target is 400 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower). The trial reports 20 study locations across 14 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03153475, a NA study of Revision Total Knee Arthroplasty, is active but no longer recruiting, sponsored by DePuy Orthopaedics.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 400 participants
- Enrollment target
- 20
- Study locations
Study Summary
Five-year, Prospective, multi-center, non-randomized, non-controlled study of the ATTUNE® Revision total knee prostheses, utilizing the fixed bearing (FB) and rotating platform (RP) tibial component with the posterior stabilizing (PS) femoral component in revision total knee arthroplasty.
Primary Outcome
To evaluate the 5 year survivorship using Kaplan-Meier survival analysis, with revision for any reason as the endpoint, for the ATTUNE® Revision TKA PS FB and PS RP configurations.
Conditions Studied
Interventions
- DEVICE ATTUNE Revision Knee System in Revision Total Knee Arthroplasty
Study Locations (20)
Other
- The Gold Coast Centre for Bone and Joint Surgery - Gold Coast
- St. John of God Murdoch Hospital - Perth
- Krankenhaus der Barmherzigen Schwestern Linz Betriebsgesellschaft m.b.H. - Linz
- MoRe Foundation - Antwerp
Colorado
- Colorado Joint Replacement - Denver
- Orthopaedic Center of the Rockies - Fort Collins
North Carolina
- UNC Orthopaedics - Chapel Hill
- OrthoCarolina Hip and Knee Center - Charlotte
Texas
- Texas Institute for Hip & Knee Surgery - Austin
- Fondren Orthopedic Group - Houston
California
- Scripps Clinic Torrey Pines - San Diego
Connecticut
- Orthopedic Partners - Niantic
Florida
- Florida Orthopedic Associates - DeLand
Kentucky
- Arthroplasty Foundation - Louisville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 400 participants |
| Start Date | 2017-05-30 |
| Est. Completion | 2029-03-31 |
| Phase | NA |
What the registry record for NCT03153475 still lists
NCT03153475 is an interventional study that assigns participants to a tested intervention. The registered 400 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (72% lower).
The record links to 1 condition, with Revision Total Knee Arthroplasty appearing as the primary indexed condition, and to 1 intervention - of which ATTUNE Revision Knee System in Revision Total Knee Arthroplasty is the first listed.
NCT03153475 names 20 study sites across 14 states, led by Other, Colorado, North Carolina.
Frequently Asked Questions
What is clinical trial NCT03153475 about?
NCT03153475 is a clinical study titled "ATTUNE Revision System in the Revision Total Knee Arthroplasty Population". Five-year, Prospective, multi-center, non-randomized, non-controlled study of the ATTUNE® Revision total knee prostheses, utilizing the fixed bearing (FB) and rotating platform (RP) tibial component with the posterior stabilizing (PS) femoral component in revision total knee arthroplasty.
What is the current status of trial NCT03153475?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 400 participants. The study started on 2017-05-30. Estimated completion is 2029-03-31.
What conditions does trial NCT03153475 study?
This clinical trial studies the following conditions: Revision Total Knee Arthroplasty.
What interventions are being tested in trial NCT03153475?
The interventions under investigation include: ATTUNE Revision Knee System in Revision Total Knee Arthroplasty (DEVICE).
Who is sponsoring clinical trial NCT03153475?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03153475 being conducted?
This trial has 20 study locations across California, Colorado, Connecticut, Florida, Kentucky. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03153475's enrollment target sits among peer trials
400 246th of 2000 higher than 1,734 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01665326 · 400 participants
Determination of CRIM Status and Longitudinal Follow-up of Individuals With Pompe Disease
- NCT02108054 · 400 participants · NA
Behavioral and Functional Task Development, Implementation, and Testing
- NCT02216500 · 400 participants · NA
Ketogenic Therapy Effects on Electrical and Metabolic Abnormalities in Epilepsy
- NCT02250352 · 400 participants
Core Biopsies for Establishing a Breast Tumor Tissue Repository
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI